Uveitis & Inflammatory Eye
"Eye redness that doesn't improve with over-the-counter drops"
What is Uveitis & Inflammatory Eye?
Uveitis is an inflammatory eye condition where the uvea—the middle layer of tissue in the eye wall that contains blood vessels—becomes inflamed, causing redness, pain, blurred vision, and light sensitivity. This inflammation can affect one or both eyes and may be acute (sudden onset) or chronic (long-lasting). While often idiopathic, uveitis frequently signals underlying autoimmune disease, infection, or systemic inflammatory conditions affecting the entire body.
Healthy Eye Function
What your eyes should do
In a healthy eye, the uvea functions as the eye's vascular and immunological powerhouse. This middle layer consists of three parts: the iris (colored part controlling pupil size), the ciliary body (producing aqueous humor and controlling lens focus), and the choroid (vascular layer supplying oxygen and nutrients to the retina). Under normal conditions, the blood-aqueous barrier maintains immune privilege, preventing inflammation while allowing selective immune surveillance. The eye's microenvironment maintains a delicate balance of anti-inflammatory cytokines, regulatory T-cells, and complement regulatory proteins that prevent inappropriate immune activation while protecting against pathogens.
When Things Go Wrong
Signs of progression
- Vision changes worsen over time
- Increased eye pain or discomfort
- Light sensitivity increases
- Daily activities become difficult
How This Develops
Understanding the biological mechanisms helps us target the root cause
Stage 1
Uveitis develops through complex immunological mechanisms involving breakdown of the blood-ocular barrier and dysregulated inflammatory responses: (1) Autoimmune activation - T-cells and B-cells mistakenly target ocular self-antigens (interphotoreceptor retinoid-binding protein, S-antigen), triggering cytokine cascades (TNF-alpha, IL-1, IL-6, IL-17) that recruit inflammatory cells. (2) Blood-ocular barrier disruption - Tight junctions between endothelial cells break down, allowing proteins and inflammatory cells to leak into aqueous humor and vitreous. (3) Complement activation - Alternative and classical complement pathways amplify inflammation and attract neutrophils and macrophages. (4) HLA genetic associations - Specific HLA alleles (HLA-B27, HLA-A29, HLA-DR4, HLA-B51) predispose to uveitis by presenting ocular antigens to T-cells. (5) Molecular mimicry - Infectious agents trigger cross-reactive immune responses against ocular tissues. (6) Cytokine storm - Pro-inflammatory mediators create a self-perpetuating cycle of tissue damage and immune activation. (7) Structural damage - Chronic inflammation leads to synechiae (iris-lens adhesions), cataracts, glaucoma, macular edema, and retinal damage through direct cellular toxicity and ischemia.
Understanding the mechanism helps us target the root cause rather than just treating symptoms.
Conditions That Occur Together
These conditions often coexist due to shared mechanisms
Ankylosing Spondylitis
HLA-B27 associated; shared inflammatory pathway between spine and eyes; 25-40% of AS patients develop acute anterior uveitis; TNF-alpha driven inflammation
Rheumatoid Arthritis
Systemic autoimmune inflammation; scleritis can extend to uveal tract; immune complex deposition and T-cell mediated damage
Sarcoidosis
Granulomatous inflammation affecting eyes; ACE-producing macrophages accumulate in ocular tissues; multisystem involvement common
Inflammatory Bowel Disease (Crohn's/Ulcerative Colitis)
Shared HLA-B27 and gut-eye axis; intestinal permeability triggers systemic immune activation; 5-10% of IBD patients develop uveitis
Psoriatic Arthritis
HLA associations; IL-17 and IL-23 pathway activation affects both skin and eyes; enthesitis-related inflammation
Behcet's Disease
HLA-B51 associated vasculitis causing severe panuveitis; neutrophilic vascular inflammation; oral and genital ulcers co-occur
Multiple Sclerosis
Optic neuritis and intermediate uveitis associations; shared demyelinating and inflammatory mechanisms
Infections (TB, Syphilis, Herpes, Toxoplasmosis)
Direct microbial invasion or immune response to infection; molecular mimicry triggering autoimmune cross-reactivity
Juvenile Idiopathic Arthritis
Chronic asymptomatic anterior uveitis in children; ANA-positive subset at highest risk; requires regular screening
Systemic Lupus Erythematosus
Autoimmune vasculitis and immune complex deposition affecting ocular vessels; retinal vasculitis common
Conditions to Rule Out
These conditions can present similarly but have distinct features
Conjunctivitis (Pink Eye)
Redness, irritation, discharge
Conjunctivitis causes superficial redness, itching, and discharge; uveitis causes deep aching pain, photophobia, and blurred vision with ciliary flush (redness concentrated around cornea)
Acute Glaucoma
Red eye, severe pain, blurred vision, headache
Glaucoma causes markedly elevated intraocular pressure (>30 mmHg), corneal edema (cloudy cornea), and fixed mid-dilated pupil; uveitis typically has normal or low pressure initially
Scleritis
Deep eye pain, redness, photophobia
Scleritis causes severe boring pain often waking patient at night; redness is deeper (bluish-purple) and does not blanch with phenylephrine; may have underlying autoimmune disease
Keratitis (Corneal Infection)
Pain, redness, photophobia, tearing
Keratitis shows corneal opacity, ulceration, or infiltrates on slit-lamp exam; dendritic pattern in herpes simplex; contact lens history common
Optic Neuritis
Vision loss, pain with eye movement
Optic neuritis causes central vision loss with relative afferent pupillary defect (RAPD); pain is primarily with eye movement; often associated with demyelinating disease
Endophthalmitis
Pain, redness, decreased vision
Endophthalmitis follows trauma or surgery; severe vitritis with hypopyon (pus in anterior chamber); vision loss is rapid and profound; infectious emergency
Episcleritis
Redness, mild discomfort
Episcleritis is superficial, sectoral redness with minimal pain; blanches with phenylephrine drops; no vision changes or photophobia
What's Driving Uveitis & Inflammatory Eye
Identifying the underlying causes allows us to target treatment effectively
Autoimmune Dysregulation
40-50% of non-infectious casesANA, RF, anti-CCP, HLA typing, extractable nuclear antigens (ENA) panel
HLA-B27 Associated Spondyloarthropathies
50-60% of acute anterior uveitisHLA-B27 testing, sacroiliac imaging, assessment for back pain and stiffness
Infectious Agents
20-30% of casesTB testing, syphilis serology, Lyme antibodies, toxoplasma IgG/IgM, HSV/VZV PCR, CMV testing
Sarcoidosis
5-10% of uveitis casesACE level, lysozyme, chest imaging, tissue biopsy if indicated
Trauma or Surgery
5-10% of casesHistory of eye injury, intraocular surgery, or foreign body
Medication-Induced
Rare but importantMedication history review (bisphosphonates, rifabutin, cidofovir, sulfonamides, oral contraceptives)
Masquerade Syndromes
1-2% (but critical to identify)Age-appropriate cancer screening, ocular ultrasound, systemic workup for lymphoma or leukemia
Idiopathic
30-40% of casesDiagnosis of exclusion after thorough infectious and autoimmune workup
Key Laboratory Markers
These biomarkers help us understand your specific condition mechanisms
What Happens If Left Untreated
Understanding the consequences helps you make informed decisions about your health
Permanent Vision Loss
Months to years if untreatedCystoid macular edema, optic nerve damage, retinal detachment, and chronic structural damage can cause irreversible blindness; uveitis accounts for 10-15% of blindness in developed countries
Cataracts
Months to yearsChronic inflammation and steroid treatment accelerate cataract formation; may require surgery which carries higher risk in inflamed eyes
Glaucoma
VariableInflammation can cause angle-closure from pupillary block or open-angle from trabecular meshwork damage; steroid treatment also elevates intraocular pressure
Retinal Detachment
Acute or chronicInflammation causes vitreous traction and retinal breaks; requires urgent surgical intervention
Hypotony and Phthisis Bulbi
Chronic severe casesCiliary body damage leads to low eye pressure, shrinking eye, and eventual loss of the eye
Band Keratopathy
ChronicCalcium deposits on cornea causing irritation and vision impairment
Systemic Disease Progression
VariableUveitis may be the first manifestation of serious systemic autoimmune disease; delayed diagnosis allows systemic organ damage
Psychological Impact
ChronicVision-threatening disease causes significant anxiety, depression, and reduced quality of life; fear of blindness affects mental health
Time Matters
Don't wait for symptoms to worsen. Early intervention leads to better outcomes.
How is Uveitis & Inflammatory Eye Diagnosed?
Comprehensive evaluation to identify triggers, contributing factors, and appropriate treatment
Comprehensive Ophthalmic Examination
Purpose:
Initial assessment and diagnosis
Slit-lamp examination reveals cells and flare in anterior chamber; keratic precipitates (inflammatory deposits on cornea); posterior synechiae; vitritis; retinal or choroidal lesions
Intraocular Pressure Measurement
Purpose:
Assess for glaucoma
May be low (ciliary body shutdown) or elevated (steroid response or angle closure); critical for management decisions
Dilated Fundus Examination
Purpose:
Assess posterior segment
Vitreous cells, retinal vasculitis, choroiditis, optic disc edema, macular edema, retinal detachments
Optical Coherence Tomography (OCT)
Purpose:
Detect macular complications
Cystoid macular edema (CME), subretinal fluid, epiretinal membrane, choroidal neovascularization; quantitative monitoring
Fluorescein Angiography
Purpose:
Assess retinal vasculature
Vasculitis, capillary leakage, neovascularization, macular edema, optic disc leakage; guides treatment decisions
Indocyanine Green Angiography (ICG)
Purpose:
Assess choroidal circulation
Choroidal vasculitis, stromal inflammation, occult lesions not visible on fluorescein
B-Scan Ultrasonography
Purpose:
Evaluate posterior segment when media is opaque
Vitreous opacities, retinal detachment, posterior scleritis, optic disc drusen, intraocular masses
Systemic Autoimmune Workup
Purpose:
Identify underlying systemic disease
ESR, CRP, ANA, RF, anti-CCP, HLA-B27, HLA-A29, ACE, ANCA, extractable nuclear antigens
Infectious Disease Testing
Purpose:
Rule out infectious causes
TB testing, syphilis serology, Lyme antibodies, toxoplasmosis titers, viral PCRs (HSV, VZV, CMV)
Supporting Your Treatment
Evidence-based lifestyle modifications to enhance treatment effectiveness
Anti-inflammatory omega-3 fatty acids: fatty fish (salmon, mackerel, sardines), flaxseeds, walnuts - reduce systemic inflammation
Colorful antioxidants: berries, leafy greens, bell peppers, sweet potatoes - combat oxidative stress in ocular tissues
Vitamin A-rich foods: carrots, sweet potatoes, spinach, kale - essential for retinal health and night vision
Vitamin C sources: citrus fruits, kiwi, bell peppers - supports collagen synthesis and immune function
Vitamin E: almonds, sunflower seeds, avocado - protects cell membranes from oxidative damage
Zinc-rich foods: oysters, pumpkin seeds, beef, lentils - critical for immune function and retinal health
Turmeric and ginger: potent anti-inflammatory compounds that may reduce autoimmune activity
Green tea: catechins have anti-inflammatory and neuroprotective properties
AVOID: Pro-inflammatory foods including processed sugars, refined carbohydrates, industrial seed oils, and excessive alcohol
AVOID: Nightshade vegetables (tomatoes, peppers, eggplant) if they trigger symptoms in sensitive individuals
Hydration: adequate water intake supports aqueous humor production and cellular function
What Success Looks Like
Complete resolution of anterior chamber cells and flare (slit-lamp examination)
Absence of vitritis on clinical examination
Resolution of cystoid macular edema on OCT (<280 microns central thickness)
Stable or improved visual acuity (maintenance of baseline or improvement)
Absence of active retinal or choroidal lesions
No new synechiae formation
Normal intraocular pressure (10-21 mmHg)
Patient-reported absence of pain and photophobia
Absence of recurrence for 6+ months
Successful taper to lowest effective medication dose
Control of underlying systemic disease (if present)
Maintenance of quality of life and daily functioning
Frequently Asked Questions
Ready to Protect Your Vision?
Our integrative approach has helped hundreds of patients restore and maintain their eye health. Schedule your comprehensive eye assessment today.